Low Fasted Absorption
When taken on an empty stomach, BPC-157 is exposed to a highly acidic gastric environment, which can degrade the peptide before it reaches the intestines. This significantly limits its stability and reduces the amount available for absorption.
As a result, bioavailability may drop to approximately 20%, meaning a large portion of the active compound is not effectively utilized by the body.
Why This Happens
-
Acidic pH Breakdown
The stomach’s low pH can disrupt peptide structure, reducing effectiveness -
Reduced Stability
Without the buffering effect of food, the compound is more vulnerable to degradation -
Limited Absorption Window
Faster gastric emptying can reduce the time available for proper uptake
What This Means
Taking BPC-157 in a fasted state may lead to suboptimal results, as less of the active peptide reaches systemic circulation where it can support repair and recovery processes.
Optimized Approach
For improved absorption and effectiveness, it is recommended to take BPC-157 after a meal, where a more balanced digestive environment helps protect the compound and enhance uptake.